I went back and re-listened to the CC and sure I was expecting more from the questions, but I did get a better sense of where we stand. with GKN, RR and really with the rest of our Aerospace customers. It also sounds like China is opening up as well.
On the Delivery front in comparison to YOY Q1 they increased it from 9 to 14, by 55%, a very good number. Another number I think we should look at it is the trailing twelve months Revenue(TTM) 624.6 mSek, which was a 62% increase YOY compared to 385.4 mSek.
We learned that 5-10 customers is using Incolnel material, so eventually this material will be proven and will be another market EBM will be able to grow into.
Again the GE order comprises "mainly" of A2X machines.
APC has about 50% of the Ti market and help explains the 71% YOY and 25% Q to Q powder growth rate. More customers, more production, more powder.
EBM has 3% of the Hip implant-acetabular cup business, that means plenty(97%) of market share to grow into.
R&D spend will continue as they invest to benefit their customers.
Magnus clarified the Order announcement policy - 20 mSek or an order they think is important to the market.
I asked a couple of questions.
one about FastEBM - and I think we have to realize that it will be incorporated over time as they develop their systems and industrialize them. FastEBM is not going to be the "end all be all" I think most of us had originally thought.
about GKN, RR, PW - I have come to realize that our Aerospace customers will be very, very long-term relationships and nothing is really imminent, but at the same time something can happen on any given day.
When Magnus was talking about the GE9X LPT Blades he also said many Aerospace companies are "moving to production as we speak and there are certain components already manufactured but cannot mention because of agreements with customers".
I think Magnus would love to shout about EBM from the rooftops, but he can't, he has to be tight lipped.
All in all Q1 was a success....
News 
Market Data 
Discover 
AI
